0001562180-18-003068.txt : 20180620 0001562180-18-003068.hdr.sgml : 20180620 20180620160722 ACCESSION NUMBER: 0001562180-18-003068 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180619 FILED AS OF DATE: 20180620 DATE AS OF CHANGE: 20180620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: IGUCHI KIMI CENTRAL INDEX KEY: 0001304815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36544 FILM NUMBER: 18909387 MAIL ADDRESS: STREET 1: 100 FOXBOROUGH BOULEVARD STREET 2: SUITE 240 CITY: FOXBOROUGH STATE: MA ZIP: 02035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sage Therapeutics, Inc. CENTRAL INDEX KEY: 0001597553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-299-8380 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-06-19 false 0001597553 Sage Therapeutics, Inc. SAGE 0001304815 IGUCHI KIMI C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 false true false false CFO & Treasurer Common Stock 2018-06-19 4 M false 800.00 0.45 A 26826.00 D Stock Option (Right to Buy) 0.45 2018-06-19 4 M false 800.00 0.00 D 2023-09-24 Common Stock 800.00 67949.00 D This balance includes employee stock purchase plans shares. The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2011 Stock Option and Incentive Plan. The option vested in full on September 16, 2017, subject to continued service through such date. /s/ Anne Marie Cook, as Attorney-in-Fact for Kimi Iguchi 2018-06-20